Trial
NCT02168270
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Anaplastic Astrocytoma
Intervention
ascorbic acid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-24